{"DataElement":{"publicId":"6732884","version":"1","preferredName":"Disease Response Assessment Modality Consideration Type","preferredDefinition":"The text response that indicates the modality and/or method considered for evaluating disease response to treatment.","longName":"DS_RESP_MOD_CONS_TYP","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"6732878","version":"1","preferredName":"Disease Response Assessment Modality Consideration","preferredDefinition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression._The final result of a determination of the value, significance, or extent of._A specific manner, characteristic, pattern of application or the employment of, any therapeutic agent or method of treatment, especially involving the physical treatment of a condition._Careful thought or deliberation.","longName":"2752004v1.0:6732876v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2752004","version":"1","preferredName":"Response Assessment","preferredDefinition":"In medicine, an improvement related to treatment.:The act of judging the value, significance, or extent of something.","longName":"C50995:C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4DDF1D38-F40B-3032-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-22","endDate":null,"createdBy":"UMLLOADER_LEADS","dateCreated":"2008-05-23","modifiedBy":"ONEDATA","dateModified":"2008-05-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6732876","version":"1","preferredName":"Modality Consideration","preferredDefinition":"A specific manner, characteristic, pattern of application or the employment of, any therapeutic agent or method of treatment, especially involving the physical treatment of a condition.:Careful thought or deliberation.","longName":"C41147:C113416","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modality","conceptCode":"C41147","definition":"A specific manner, characteristic, pattern of application or the employment of, any therapeutic agent or method of treatment, especially involving the physical treatment of a condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Consideration","conceptCode":"C113416","definition":"Careful thought or deliberation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8765326E-9F93-02FF-E053-F662850A4E43","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2233241","version":"1","preferredName":"Medical Imaging","preferredDefinition":"Events, people, materials and activities uniquely defined by medical imaging.  ","longName":"MEDICAL IMAGING","context":"CIP","contextVersion":"2.31","origin":"DICOM:Digital Imaging and Communications in Medicine","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F96173D7-A9B4-3CBB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-12","modifiedBy":"SBREXT","dateModified":"2006-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8765326E-9FA4-02FF-E053-F662850A4E43","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"HARTLEYG","dateModified":"2019-05-01","changeDescription":"PTCL content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6732879","version":"1","preferredName":"Disease Response Assessment Modality Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6732879v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"mSWAT","valueDescription":"Modified Severity Weighted Assessment Tool","ValueMeaning":{"publicId":"6734255","version":"1","preferredName":"Modified Severity Weighted Assessment Tool","longName":"6734255","preferredDefinition":"A clinical measurement tool for measuring skin tumor burden in mycosis fungoides (MF) and Sezary syndrome (SS). It involves determining the percentage of body surface area (BSA) covered by patch, plaque, or tumor of MF/SS, then multiplying each lesion BSA by a factor that gives gradations of weight to patch versus plaque versus tumor and summing these scores. The change in mSWAT from the beginning of treatment can be used to assess overall response.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Modified Severity Weighted Assessment Tool","conceptCode":"C159687","definition":"A clinical measurement tool for measuring skin tumor burden in mycosis fungoides (MF) and Sezary syndrome (SS). It involves determining the percentage of body surface area (BSA) covered by patch, plaque, or tumor of MF/SS, then multiplying each lesion BSA by a factor that gives gradations of weight to patch versus plaque versus tumor and summing these scores. The change in mSWAT from the beginning of treatment can be used to assess overall response.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8776641E-4EE7-01A9-E053-F662850A899D","latestVersionIndicator":"Yes","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8776641E-4F00-01A9-E053-F662850A899D","beginDate":"2019-04-26","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-26","modifiedBy":"ONEDATA","dateModified":"2019-04-26","deletedIndicator":"No"},{"value":"Morphology - Bone Marrow","valueDescription":"Bone Marrow Morphology","ValueMeaning":{"publicId":"2974015","version":"1","preferredName":"Bone Marrow Morphology","longName":"2974015","preferredDefinition":"The soft, sponge-like tissue in the center of bones that produces white blood cells, red blood cells, and platelets.: Morphology is the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow","conceptCode":"C12431","definition":"The tissue occupying the spaces of bone. It consists of blood vessel sinuses and a network of hematopoietic cells which give rise to the red cells, white cells, and megakaryocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Morphology","conceptCode":"C17943","definition":"The science of the form and structure of organisms (plants, animals, and other forms of life), or of their parts, and the study or science of the same.  In pathology, the specific appearance of cells and tissues (normal and abnormal) under the light or electron microscope.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7BCD2B56-10D3-3667-E040-BB89AD436539","latestVersionIndicator":"Yes","beginDate":"2009-12-28","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-12-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8762E624-F0E0-5448-E053-F662850A970F","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"Flow Cytometry - Bone Marrow","valueDescription":"Bone Marrow Flow Cytometry","ValueMeaning":{"publicId":"6732881","version":"1","preferredName":"Bone Marrow Flow Cytometry","longName":"6732881","preferredDefinition":"Flow cytometry using cells derived from a bone marrow sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Marrow Flow Cytometry","conceptCode":"C38063","definition":"Flow cytometry using cells derived from a bone marrow sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8762E624-F0EE-5448-E053-F662850A970F","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8762E624-F107-5448-E053-F662850A970F","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"Flow Cytometry - Blood","valueDescription":"Blood Flow Cytometry","ValueMeaning":{"publicId":"6732883","version":"1","preferredName":"Blood Flow Cytometry","longName":"6732883","preferredDefinition":"Flow cytometry used to examine and quantitate the constituents of the blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Blood Flow Cytometry","conceptCode":"C38062","definition":"Flow cytometry used to examine and quantitate the constituents of the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8762E624-F114-5448-E053-F662850A970F","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8762E624-F12D-5448-E053-F662850A970F","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"MRI","valueDescription":"Magnetic Resonance Imaging","ValueMeaning":{"publicId":"5612205","version":"1","preferredName":"Magnetic Resonance Imaging","longName":"5612205","preferredDefinition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide amazingly clear and detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Magnetic Resonance Imaging","conceptCode":"C16809","definition":"Imaging that uses radiofrequency waves and a strong magnetic field rather than x-rays to provide detailed pictures of internal organs and tissues. The technique is valuable for the diagnosis of many pathologic conditions, including cancer, heart and vascular disease, stroke, and joint and musculoskeletal disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E62105-9639-3714-E053-F662850A1CAC","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ALEYR","dateCreated":"2016-12-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8762E624-F137-5448-E053-F662850A970F","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"CT","valueDescription":"Computed Tomography","ValueMeaning":{"publicId":"5612204","version":"1","preferredName":"Computed Tomography","longName":"5612204","preferredDefinition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Computed Tomography","conceptCode":"C17204","definition":"A method of examining structures within the body by scanning them with X rays and using a computer to construct a series of cross-sectional scans along a single axis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44E62105-9616-3714-E053-F662850A1CAC","latestVersionIndicator":"Yes","beginDate":"2016-12-30","endDate":null,"createdBy":"ALEYR","dateCreated":"2016-12-30","modifiedBy":"KUMMEROA","dateModified":"2023-03-30","changeDescription":null,"administrativeNotes":"2023.3.21 Alt VM added per ticket request CADSR0002164. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8762E624-F141-5448-E053-F662850A970F","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"PET","valueDescription":"Positron Emission Tomography","ValueMeaning":{"publicId":"2919109","version":"1","preferredName":"Positron Emission Tomography","longName":"2919109","preferredDefinition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography","conceptCode":"C17007","definition":"A technique for measuring the gamma radiation produced by collisions of electrons and positrons (anti-electrons) within living tissue. In positron emission tomography (PET), a subject is given a dose of a positron-emitting radionuclide attached to a metabolically active substance (for example, 2-fluoro-2-deoxy-D-glucose (FDG), which is similar to a naturally occurring sugar, glucose, with the addition of a radioactive fluorine atom). When living tissue containing the positron emitter is bombarded by electrons, gamma radiation produced by collisions of electrons and positrons is detected by a scanner, revealing in fine detail the tissue location of the metabolically-active substance administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6EAE3776-A836-6030-E040-BB89AD432E08","latestVersionIndicator":"Yes","beginDate":"2009-07-14","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-07-14","modifiedBy":"KUMMEROA","dateModified":"2023-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8762E624-F14B-5448-E053-F662850A970F","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"},{"value":"PET/CT","valueDescription":"Positron Emission Tomography and Computed Tomography Scan","ValueMeaning":{"publicId":"5627465","version":"1","preferredName":"Positron Emission Tomography and Computed Tomography Scan","longName":"5627465","preferredDefinition":"An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positron Emission Tomography and Computed Tomography Scan","conceptCode":"C103512","definition":"An imaging technique that utilizes positron emission tomography and computed tomography in a single machine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45FAA3A8-A426-2E10-E053-F662850ACE95","latestVersionIndicator":"Yes","beginDate":"2017-01-13","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2017-01-13","modifiedBy":"KUMMEROA","dateModified":"2023-03-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8762E624-F155-5448-E053-F662850A970F","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"ONEDATA","dateModified":"2019-04-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8762E624-F0BF-5448-E053-F662850A970F","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"HARTLEYG","dateModified":"2019-05-01","changeDescription":"PTCL content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6705584","version":"1","longName":"CCG PTCL (Center for Cancer Genomics - Peripheral T Cell Lymphoma)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6705585","version":"1","longName":"PTCL","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Modalities considered in trea","type":"Preferred Question Text","description":"Modalities considered in treatment response assessment","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8762F683-4D64-7291-E053-F662850A4514","latestVersionIndicator":"Yes","beginDate":"2019-04-25","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-25","modifiedBy":"HARTLEYG","dateModified":"2019-05-01","changeDescription":"PTCL content","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}